Literature DB >> 11102902

Clinical and genetic heterogeneity in myotonic dystrophies.

G Meola1.   

Abstract

This review of myotonic dystrophies primarily concentrates on the clinical and genetic findings that can distinguish a novel form of myotonic dystrophy, myotonic dystrophy type 2 (DM2); proximal myotonic myopathy (PROMM); and proximal myotonic dystrophy (PDM) from myotonic dystrophy type 1 (DM1). The multisystemic nature of these disorders leads to a spectrum of symptoms and signs. Careful clinical evaluation of patients with DM2/PROMM shows that the similarities among the multisystemic myotonic disorders outweigh the differences. An important point in the comparison of the phenotypes of DM1 and DM2/PROMM is that no severe congenital type of DM2/PROMM has yet been described. Genetic linkage analyses show that myotonic dystrophies can be divided into three types: the conventional Steinert type linked to chromosome 19q13.3 (DM1); DM2/PROMM and PDM linked to chromosome 3q21.3; and families not linked to either chromosomal site. Although the diagnosis may be clinically suspected, it depends on DNA analysis. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 11102902     DOI: 10.1002/1097-4598(200012)23:12<1789::aid-mus2>3.0.co;2-4

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  18 in total

1.  Proximal myopathy and diffuse white matter involvement in myotonic dystrophy type I.

Authors:  Kayihan Uluc; E Murat Arsava; Sevim Erdem; Ersin Tan
Journal:  J Neurol       Date:  2002-05       Impact factor: 4.849

Review 2.  Structures of trinucleotide repeats in human transcripts and their functional implications.

Authors:  Anna Jasinska; Gracjan Michlewski; Mateusz de Mezer; Krzysztof Sobczak; Piotr Kozlowski; Marek Napierala; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

Review 3.  Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

Review 4.  Myotonic dystrophy type 2 and related myotonic disorders.

Authors:  Giovanni Meola; Richard T Moxley
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

Review 5.  Neuromuscular disorders and sleep.

Authors:  Ibrahim Oztura; Christian Guilleminault
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

6.  Cardiac autonomic nervous system in patients with myotonic dystrophy type 1.

Authors:  V Rakocević-Stojanović; B Milovanović; N Ivić; T Ille; I Marjanović; Z Stević; S Pavlović; D Lavrnić
Journal:  Acta Myol       Date:  2007-10

7.  Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2).

Authors:  Sergio Salvatori; Sandra Furlan; Marina Fanin; Anne Picard; Ebe Pastorello; Vincenzo Romeo; Carlo Pietro Trevisan; Corrado Angelini
Journal:  Neurol Sci       Date:  2009-03-27       Impact factor: 3.307

8.  Sleep disturbances in myotonic dystrophy type 2.

Authors:  Paul Shepard; Erek M Lam; Erik K St Louis; Jacob Dominik
Journal:  Eur Neurol       Date:  2012-10-25       Impact factor: 1.710

9.  Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to child.

Authors:  Marjan De Rademaeker; Willem Verpoest; Martine De Rycke; Sara Seneca; Karen Sermon; Sonja Desmyttere; Maryse Bonduelle; Josianne Van der Elst; Paul Devroey; Inge Liebaers
Journal:  Eur J Hum Genet       Date:  2009-04-15       Impact factor: 4.246

Review 10.  Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.

Authors:  Andrea Romigi; Valentina Franco; Fabio Placidi; Claudio Liguori; Emanuele Rastelli; Giuseppe Vitrani; Diego Centonze; Roberto Massa
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-31       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.